Decoding hypervirulence in carbapenem-resistant Klebsiella pneumoniae: genomic and phenotypic profiling reveals capsular polysaccharide as a key driver of pathogenicity.
Summary
Integrating animal virulence testing with GWAS and transcriptomics, this study shows that capsule production—regulated by rcsA—and hypermucoviscosity are the best discriminators of truly hypervirulent CRKP. A chromosomal SNP signal (rbtT locus) rather than plasmid-borne genes associates with hypervirulence, and capsule/rcsA expression emerge as robust diagnostic biomarkers.
Key Findings
- Capsule production and hypermucoviscosity robustly discriminate hv-CRKP from other CRKP isolates.
- GWAS links a chromosomal SNP at the rbtT locus to hypervirulence, while plasmid virulence genes are not significantly associated.
- rcsA-mediated capsule upregulation enhances resistance to macrophage phagocytosis; capsule production and rcsA are validated as strong diagnostic biomarkers.
Clinical Implications
Laboratories can prioritize capsule/hypermucoviscosity phenotyping and rcsA expression for rapid virulence stratification of CRKP, supporting early source control, isolation, and targeted therapy decisions.
Why It Matters
It reframes hv-CRKP pathogenesis around chromosomally driven capsule control and provides practical biomarkers to distinguish truly hypervirulent strains, directly informing diagnostics and infection control.
Limitations
- Single animal challenge model (subcutaneous) may not capture systemic sepsis dynamics
- External clinical validation across diverse geographies and strain backgrounds is pending
Future Directions
Prospective clinical validation of capsule/rcsA biomarkers, development of rapid assays, and exploration of anti-capsule strategies to mitigate hv-CRKP.
Study Information
- Study Type
- Case-control
- Research Domain
- Pathophysiology
- Evidence Level
- IV - Mechanistic and observational comparisons without randomized allocation; translational preclinical evidence with limited clinical correlation.
- Study Design
- OTHER